Overview

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Status:
Completed

Trial end date:
2015-10-01

Target enrollment:

Participant gender:

Summary

To see if Lucentis 0.5mg combined with Targeted Pan Retinal photocoagulation will decrease the total number of intravitreal injections in a year for ischemic central retinal vein occlusion, hemi-retinal vein occlusions and branch retinal vein occlusions compared to standard of care

Phase:

Phase 4

Details

Lead Sponsor:

Charles C Wykoff, PhD, MD

Collaborator:

Genentech, Inc.

Treatments:

Bevacizumab
Ranibizumab